Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy [3]

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)825-828
Number of pages4
JournalBone marrow transplantation
Volume38
Issue number12
DOIs
StatePublished - Dec 2006

Cite this